Literature DB >> 2425036

Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies.

U Storb, C Pinkert, B Arp, P Engler, K Gollahon, J Manz, W Brady, R L Brinster.   

Abstract

Transgenic mice were produced that carried in their germlines rearranged kappa and/or mu genes with V kappa and VH regions from the myeloma MOPC-167 kappa and H genes, which encode anti-PC antibody. The mu genes contain either a complete gene, including the membrane terminus (mu genes), or genes in which this terminus is deleted and only the secreted terminus remains (mu delta mem genes). The mu gene without membrane terminus is expressed at as high a level as the mu gene with the complete 3' end, suggesting that this terminus is not required for chromatin activation of the mu locus or for stability of the mRNA. The transgenes are expressed only in lymphoid organs. In contrast to our previous studies with MOPC-21 kappa transgenic mice, the mu transgene is transcribed in T lymphocytes as well as B lymphocytes. Thymocytes from mu and kappa mu transgenic mice display elevated levels of M-167 mu RNA and do not show elevated levels of kappa RNA, even though higher than normal levels of M-167 kappa RNA are detected in the spleen of these mice. Approximately 60% of thymocytes of mu transgenic mice produce cytoplasmic mu protein. However, despite a large amount of mu RNA of the membrane form, mu protein cannot be detected on the surface of T cells, perhaps because it cannot associate with T cell receptor alpha or beta chains. Mice with the complete mu transgene produce not only the mu transgenic mRNA but also considerably increased amounts of kappa RNA encoded by endogenous MOPC-167 like kappa genes. This suggests that B cells are selected by antigen (PC) if they coexpress the mu transgene and appropriate anti-PC endogenous kappa genes. Mice with the mu delta mem gene, however, do not express detectable levels of the endogenous MOPC-167 kappa mRNA. Like the complete mu transgene, the M-167 kappa transgene also causes amplification of endogenous MOPC-167 related immunoglobulins; mice with the kappa transgene have increased amounts of endogenous MOPC-167-like mu or alpha or gamma in the spleen, all of the secreted form. Implications for the regulation of immunoglobulin gene expression and B cell triggering are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425036      PMCID: PMC2188231          DOI: 10.1084/jem.164.2.627

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.

Authors:  A K Abbas; S Haber; K L Rock
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

2.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

3.  Transmission and expression of a specific pair of rearranged immunoglobulin mu and kappa genes in a transgenic mouse line.

Authors:  S Rusconi; G Köhler
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

4.  The major histocompatibility complex-restricted antigen receptor on T cells: distribution on thymus and peripheral T cells.

Authors:  N Roehm; L Herron; J Cambier; D DiGuisto; K Haskins; J Kappler; P Marrack
Journal:  Cell       Date:  1984-09       Impact factor: 41.582

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Introduction of a mu immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody.

Authors:  R Grosschedl; D Weaver; D Baltimore; F Costantini
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  A transgenic immunoglobulin mu gene prevents rearrangement of endogenous genes.

Authors:  D Weaver; F Costantini; T Imanishi-Kari; D Baltimore
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

10.  Pre-B cells in kappa-transgenic mice.

Authors:  U Storb; K A Denis; R L Brinster; O N Witte
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

View more
  43 in total

1.  Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.

Authors:  B Nelsen; T Kadesch; R Sen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

2.  The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.

Authors:  K B Meyer; M J Sharpe; M A Surani; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice.

Authors:  A Annweiler; U Müller; T Wirth
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

4.  DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae.

Authors:  Nicholas W Kin; Dianna M Crawford; Jiabin Liu; Timothy W Behrens; John F Kearney
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  In vivo role of B lymphocytes in somatic transgene immunization.

Authors:  S Xiong; M Gerloni; M Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Expression of T-cell receptor alpha-chain genes in transgenic mice.

Authors:  L J Berg; B Fazekas de St Groth; F Ivars; C C Goodnow; S Gilfillan; H J Garchon; M M Davis
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

Review 7.  Gamma 2b transgenic mice as a model for the role of immunoglobulins in B cell development.

Authors:  U Storb; P Roth; B K Kurtz
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

8.  Coinjection strategy for visual identification of transgenic mice.

Authors:  P A Overbeek; E Aguilar-Cordova; G Hanten; D L Schaffner; P Patel; R M Lebovitz; M W Lieberman
Journal:  Transgenic Res       Date:  1991-12       Impact factor: 2.788

9.  Similarities and differences between selective and nonselective BAFF blockade in murine SLE.

Authors:  Meera Ramanujam; Xiaobo Wang; Weiqing Huang; Zheng Liu; Lena Schiffer; Haiou Tao; Daniel Frank; Jeffrey Rice; Betty Diamond; Karl O A Yu; Steven Porcelli; Anne Davidson
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808

10.  Rearrangement and expression of endogenous immunoglobulin genes occur in many murine B cells expressing transgenic membrane IgM.

Authors:  A M Stall; F G Kroese; F T Gadus; D G Sieckmann; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.